A detailed history of Credit Suisse Ag transactions in Replimune Group, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 37,859 shares of REPL stock, worth $502,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,859
Previous 37,859 -0.0%
Holding current value
$502,010
Previous $319,000 3.13%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$6.75 - $16.18 $13,257 - $31,777
1,964 Added 5.47%
37,859 $319,000
Q3 2023

Nov 13, 2023

SELL
$15.96 - $22.18 $129,371 - $179,791
-8,106 Reduced 18.42%
35,895 $614,000
Q2 2023

Aug 11, 2023

BUY
$15.65 - $24.1 $176,532 - $271,848
11,280 Added 34.47%
44,001 $1.02 Million
Q1 2023

May 10, 2023

BUY
$17.48 - $29.09 $102,939 - $171,311
5,889 Added 21.95%
32,721 $577,000
Q4 2022

Feb 13, 2023

BUY
$17.09 - $27.91 $129,798 - $211,976
7,595 Added 39.48%
26,832 $729,000
Q3 2022

Nov 10, 2022

BUY
$15.6 - $21.15 $36,878 - $49,998
2,364 Added 14.01%
19,237 $333,000
Q2 2022

Aug 12, 2022

BUY
$13.32 - $19.98 $6,540 - $9,810
491 Added 3.0%
16,873 $294,000
Q1 2022

May 16, 2022

BUY
$15.24 - $29.75 $6,080 - $11,870
399 Added 2.5%
16,382 $278,000
Q4 2021

Feb 14, 2022

BUY
$25.43 - $34.25 $25,150 - $33,873
989 Added 6.6%
15,983 $433,000
Q3 2021

Nov 12, 2021

BUY
$28.98 - $39.54 $21,561 - $29,417
744 Added 5.22%
14,994 $445,000
Q2 2021

Aug 16, 2021

SELL
$28.5 - $39.37 $145,464 - $200,944
-5,104 Reduced 26.37%
14,250 $547,000
Q1 2021

May 14, 2021

SELL
$30.22 - $45.57 $926,091 - $1.4 Million
-30,645 Reduced 61.29%
19,354 $590,000
Q4 2020

Feb 12, 2021

BUY
$23.5 - $52.65 $927,662 - $2.08 Million
39,475 Added 375.1%
49,999 $1.91 Million
Q3 2020

Nov 13, 2020

BUY
$18.85 - $27.0 $198,377 - $284,148
10,524 New
10,524 $242,000
Q2 2020

Aug 12, 2020

SELL
$9.76 - $25.95 $477,498 - $1.27 Million
-48,924 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$8.9 - $19.08 $435,423 - $933,469
48,924 New
48,924 $487,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $654M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.